Every couple who has been through multiple failed IVF cycles reaches a moment — specific, memorable, often quiet — when they look at each other and have the conversation they had been avoiding.

The conversation about stopping.

It is not a conversation about giving up in the way that phrase is sometimes used — casually, as if giving up is simply a failure of persistence. It is a conversation that comes after genuine persistence has been sustained for months or years. After money has been spent that took years to save. After bodies have been through procedures that were never comfortable and were sometimes frightening. After hopes have been raised and collapsed more times than either person can count without feeling the grief of each one fresh.

The conversation sounds different for different couples. For some it is gentle — an acknowledgment that they cannot continue, emotionally or financially, and that they need to begin imagining a different kind of future. For others it is more urgent — a moment of genuine crisis, where continuing feels impossible but stopping feels unbearable. For others still it is made almost for them — by a clinic that suggests there is nothing more to try, or by a financial reality that has finally reached its limit.

Every couple who appears in this article had that conversation. Every one of them came, after it, to Metro IVF — some having been pointed toward Dr. Soni by someone who knew their story, some having found their way through a last online search, some having received a phone call from a relative who had heard about a doctor in Ambikapur who found what others missed.

And in each case — one more time, one last cycle, one final attempt — the outcome was different.

This article tells those stories. Not to suggest that every last attempt succeeds — it does not, and honesty requires acknowledging that. But to make the case, with clinical specificity and genuine narrative, that the decision to try one more time is worth making when that one more time is preceded by the investigation that all the previous times were missing.

What Makes a "Last Attempt" Different — The Clinical Argument

Before the stories, a clinical observation that is central to understanding why last attempts at Metro IVF are different from last attempts elsewhere.

In most cases, by the time a couple describes their next IVF attempt as their last, they have been through two, three, four, or more cycles at clinics that applied essentially the same approach each time — with minor protocol modifications that did not fundamentally change the assumptions on which treatment was based. Each cycle added to the financial cost, the physical toll, and the emotional exhaustion. But each cycle was, in important clinical respects, a repetition of the previous one.

At Metro IVF, a "last attempt" is not a repetition. It is a complete re-evaluation — of both partners, of every previous cycle's data, of every investigation that was or was not performed — followed by a treatment plan that is genuinely different from everything that preceded it, designed around specific findings that previous clinics never identified.

This is not a promise that the last attempt will succeed. It is a clinical commitment that the last attempt will, at minimum, be the most thoroughly prepared, most honestly evaluated, and most specifically designed attempt that the couple has ever made. Whatever the outcome, it will not be a repetition of what has already failed. And in the majority of cases — not all, but the majority — that difference changes the outcome.

Story One: Geeta and Ramakant — Four Failures, One Finding

Geeta and Ramakant came to Metro IVF describing their intended visit as exploratory. They had decided, privately, before making the appointment, that whatever Dr. Soni said, this would be their last engagement with fertility treatment. Four IVF cycles over three years — at two different clinics — had depleted their savings, their energy, and their willingness to sustain hope through another failure.

Geeta was 36. Ramakant was 39. Their previous cycles had produced embryos — good embryos, according to the embryologists at each clinic — that had simply not implanted. Lining was adequate. Stimulation was reasonable. Standard explanations had been offered after each failure. Nothing specific had been identified. Nothing specific had been investigated beyond the baseline.

Dr. Soni's reading of their four cycle records — ninety minutes of careful attention to monitoring data, embryology reports, and transfer records — produced a list of investigations that had never been performed. ERA testing. Sperm DNA fragmentation. Endometrial biopsy for chronic endometritis. Immunological panel.

The ERA revealed that Geeta's implantation window was displaced by thirty-six hours from the standard assumed timing. Every one of her four previous embryo transfers had been performed at the standard time — thirty-six hours before her endometrium was actually receptive.

The sperm DNA fragmentation test revealed a DFI of 29 percent — moderately elevated, entirely absent from Ramakant's previous evaluations, and consistent with the pattern of fertilization occurring but implantation consistently failing.

The endometrial biopsy confirmed chronic endometritis — a low-grade uterine infection that had been present and undetected throughout all four previous cycles.

Three specific findings. Three correctable problems. All present throughout four cycles of treatment at two clinics. None previously identified.

The chronic endometritis was treated with targeted antibiotics confirmed through culture sensitivity. The next cycle used testicular sperm to minimize DNA fragmentation. The embryo transfer was timed thirty-six hours later than standard — to Geeta's personalized ERA window.

One transfer. Geeta's first positive blood test in three years of IVF.

The pregnancy continued through all three trimesters without complication. Geeta and Ramakant's son was born at thirty-nine weeks. Ramakant described the day of his son's birth as the day he stopped being able to explain, in any rational terms, why they had almost stopped before it.

Story Two: Fatima and Irfan — The Cycle They Almost Did Not Book

Fatima and Irfan had been through three IVF cycles at a clinic in a larger city. After the third failure, the clinic's suggestion — delivered in a brief consultation — was to consider donor eggs, as Fatima's ovarian reserve had declined to a level the clinic considered insufficient for further autologous IVF.

Fatima was 38. Her AMH was 0.4 ng/mL — low, but not undetectable. Her antral follicle count was four.

They had almost accepted the donor egg recommendation. The conversation about stopping autologous IVF and beginning the process of considering egg donation had begun. And then a friend — a woman from Raipur who had come to Metro IVF the previous year — suggested that before accepting that conclusion, they speak with Dr. Soni.

The consultation at Metro IVF was, by Fatima's account, the first time a doctor had told her that low AMH and a low antral follicle count did not mean zero chance with her own eggs — it meant fewer eggs, and therefore the need for a different stimulation approach designed to obtain the best possible quality from the limited quantity available, rather than a standard high-dose protocol that was likely producing poor-quality eggs from a depleted reserve.

Dr. Soni recommended a modified natural cycle approach — working with what Fatima's ovaries could naturally produce rather than attempting to force a multi-follicle response that her reserve could not sustain. He recommended a full sperm DNA fragmentation assessment for Irfan — which had never been performed. He recommended hysteroscopy, which had never been performed across three previous cycles.

Irfan's DFI was 24 percent — moderate, but above the threshold considered optimal. Hysteroscopy found a small polyp — not detected on any previous ultrasound — at the posterior wall of the uterine cavity.

The polyp was removed. The next cycle was a modified natural cycle — one follicle, carefully monitored, timed precisely. One egg retrieved. Fertilized using ICSI with ejaculated sperm following a period of antioxidant pre-treatment. One blastocyst produced. Transferred at the time Fatima's ERA — performed in this cycle — identified as her personalized window.

Positive blood test. Confirmed heartbeat at seven weeks. Delivered at term.

Fatima's son — conceived with her own eggs at 38, from a cycle that produced a single blastocyst from a single follicle — was born healthy. The clinic that had recommended donor eggs received the news, some months later, through the friend who had connected them to Metro IVF.

Story Three: Nalini and Prakash — When Stopping Felt Like the Only Option

Of the stories in this article, Nalini and Prakash's is perhaps the most difficult — because by the time they reached Metro IVF, stopping did not merely feel like an option. It felt, to both of them, like the only reasonable conclusion to a process that had cost them more than they had ever expected to spend and produced nothing but grief.

They had been through five IVF cycles over four years. Two clinics. Five embryo transfers. Two early positive blood tests that ended in chemical pregnancy before six weeks. Three transfers with no implantation at all.

Nalini was 40. She had been told, after the fifth failure, that her age was the primary limiting factor — that her egg quality had declined beyond the point where further autologous IVF was likely to succeed, and that donor eggs represented her most realistic path to parenthood.

She and Prakash had begun the process of accepting this. They had had the conversations. They had cried together through them. They had begun, slowly and painfully, to separate their sense of their future family from the biological specifics of its origins.

And then Prakash's sister — who lived near Ambikapur — mentioned Metro IVF and Dr. Soni. Not with urgency. Not with the promise that it would change everything. Just as a suggestion — one more conversation, if they had it in them.

They did not feel they had it in them. But they made the appointment.

The evaluation at Metro IVF was, for both of them, unlike anything in their previous experience. Dr. Soni read every cycle record. He identified, systematically, what had been investigated and what had not. He told them that their situation was genuinely difficult — that Nalini's age was a real clinical consideration, that the pattern of two chemical pregnancies and three non-implantations was consistent with a combination of chromosomal issues in the embryos and a possible immunological barrier — and that the investigation required to confirm or rule out each of these factors had not been performed.

He did not promise success. He was explicit about that. He told them that what he could offer was a different evaluation and a genuinely different approach — and that if the evaluation found what he suspected it might find, the next cycle would be different in ways that the previous five had never been.

The investigation found three things. PGT-A had never been performed — and given Nalini's age, the probability that her previous embryos had been chromosomally abnormal was high. Sperm DNA fragmentation testing revealed a DFI of 32 percent in Prakash — never previously tested, consistent with the two chemical pregnancies that had occurred and then ended. And an antiphospholipid antibody panel — never previously ordered — was positive, with anticardiolipin antibodies confirmed on two separate occasions.

The approach for the next cycle was specific to these findings. PGT-A was performed — producing two euploid embryos from a cycle that generated five blastocysts. Testicular sperm was used for fertilization — bypassing the elevated ejaculatory DFI. Anticoagulation therapy — low-dose aspirin initiated before transfer, low-molecular-weight heparin from the day of transfer — addressed the antiphospholipid syndrome that had likely disrupted placentation in both previous chemical pregnancies.

The first euploid embryo transferred — anticoagulation in place, DNA-intact sperm having fertilized the egg, chromosomal normality confirmed before transfer — implanted. The pregnancy continued past the point at which both previous chemical pregnancies had ended. Past twelve weeks. Past twenty weeks.

Nalini and Prakash's daughter was born at thirty-eight weeks. She weighed three kilograms and two hundred grams. She had, according to her father's account of her first hours, an expression of complete composure that he found both funny and deeply moving.

He said, in the car on the way home from the hospital — the car containing him, his wife, and a person who had not existed in the world five cycles ago — that he thought about all the conversations they had had about stopping. All the reasonable arguments they had constructed, carefully and painfully, for why it was time to accept a different future. And that he was glad — profoundly, permanently glad — that they had made one more appointment before those conversations became final.

The Clinical Pattern Across These Stories

Three stories. Three different durations. Three different specific findings. But a clinical pattern that runs through all of them — and through the broader category of last-attempt IVF success at Metro IVF — that is worth identifying explicitly.

In every case, the factor or factors that were eventually found and treated had been present throughout every previous cycle. The displaced implantation window, the chronic endometritis, the sperm DNA fragmentation — in Geeta and Ramakant's case. The polyp, the DNA fragmentation — in Fatima and Irfan's. The chromosomal abnormalities in the embryos, the sperm DNA damage, the antiphospholipid syndrome — in Nalini and Prakash's.

None of these factors developed between the previous cycles and the last one. They were there from the beginning. What changed was not the biology. What changed was the investigation — the application, finally, of a sufficiently thorough clinical work-up to identify what had been silently preventing implantation or sustaining pregnancy across every previous attempt.

The last attempt succeeded not because of luck, or persistence, or the statistical inevitability of trying enough times. It succeeded because the last attempt was, for the first time, genuinely different — based on genuine diagnostic information rather than on repeated applications of the same assumptions.

This is the argument for one more attempt — not as an act of blind faith, but as an act of clinical reasoning. If the previous attempts were conducted without the investigation that might have identified the real problem, then those attempts have not exhausted the possibilities. They have exhausted a particular approach. The possibilities remain open until the right investigation has been applied to finding them.

For the Couple Having the Conversation About Stopping

If you are at the point where the conversation about stopping has begun — if you are reading this because you are trying to decide whether one more attempt is hope or futility — this article is written specifically for you.

Not to tell you that you must continue. The decision to stop treatment is a valid, autonomous, deeply personal decision that deserves respect and support whatever form it takes.

But to tell you this: if you have been through multiple IVF cycles and none of them included the comprehensive investigation described in the stories above — if ERA has not been done, if sperm DNA fragmentation has not been tested, if hysteroscopy has never been performed, if PGT-A has never been used, if immunological testing has never been ordered — then the investigation that might change the outcome has not yet been performed.

That investigation is available at Metro IVF in Ambikapur. The consultation that precedes it is a conversation with Dr. Ashish Soni — a doctor who will read every previous cycle record carefully, identify specifically what has not been investigated, and tell you honestly what he finds and what he thinks it means for your situation.

He will not promise success. He will not tell you that the next cycle will work. He will tell you what the investigation reveals — and whether what it reveals changes the picture enough to justify one more attempt, or whether the honest picture is one that supports a different path.

That honest conversation — whatever it concludes — is worth having before the conversation about stopping becomes permanent.

Your Next Step

If you are almost ready to give up — if you have been through cycles that did not work and are carrying the weight of that history into a decision about whether to try once more — come to Metro IVF first.

Bring every report. Every cycle summary. Every investigation result. Everything you have.

Dr. Soni will read all of it. He will find what has not been investigated. He will tell you what the findings mean. And he will give you — whatever the conclusion — the most honest, thorough, and clinically complete assessment of your situation that medicine can currently provide.

That assessment is worth having before any final decision. Because the decision to stop, made with complete information, is a different decision from the decision to stop made without it. And because in some cases — in the cases told in this article, and in others like them — what the complete information reveals is that one more attempt, finally designed around what was actually wrong, is the one that changes everything.

Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist

Almost ready to give up? Before you do — find out if the investigation that could change everything has actually been performed. Book your consultation with Dr. Soni at Metro IVF today.